Jared Weiss, MD, associate professor in the division of oncology, led a recent discussion about a 59.year-old patient with RET-fusion-positive non–small cell lung cancer (NSCLC) during a Targeted Oncology Case-Based Roundtable event.
Roundtable Discussion: Weiss Discusses Treatment of RET-Fusion Mutations in NSCLC